Back to Search
HAROLD PELZER, MD
Otolaryngology Physician
NPI: 1528092871Individual
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
Research & Publications (19)
Prevalence of penicillin allergy in adults with peritonsillar abscess.
PMID 15929323·Ear Nose Throat J·2005
8-other
Preoperative radiation therapy and its effects on outcomes in microsurgical head and neck reconstruction.
PMID 15944552·Otolaryngol Head Neck Surg·2005
4-observational
Advances in surgical management of malignancies of the cranial base: the extended transbasal approach.
PMID 15981105·J Neurooncol·2005
3-trial
Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer.
PMID 15229906·Head Neck·2004
8-other
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
PMID 15297392·Clin Cancer Res·2004
3-trial
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
PMID 15277256·Ann Oncol·2004
4-observational
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
PMID 15122662·Head Neck·2004
8-other
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.
PMID 12881397·Ann Oncol·2003
4-observational
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
PMID 12525525·J Clin Oncol·2003
8-other
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
PMID 12738722·Clin Cancer Res·2003
3-trial
Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.
PMID 14630255·Int J Radiat Oncol Biol Phys·2003
6-review
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
PMID 14676118·Clin Cancer Res·2003
8-other
Does laryngectomy improve swallowing after chemoradiotherapy? A case study.
PMID 11784255·Arch Otolaryngol Head Neck Surg·2002
5-case
Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers.
PMID 11992387·Int J Cancer·2001
8-other
Leiomyosarcoma of the sinonasal tract: report of a case.
PMID 11743476·Otolaryngol Head Neck Surg·2001
5-case
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
PMID 11283128·J Clin Oncol·2001
3-trial
Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9.
PMID 10862014·Head Neck·2000
8-other
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
PMID 10922226·Arch Otolaryngol Head Neck Surg·2000
6-review
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
PMID 10764425·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 680 N LAKE SHORE DR, SUITE 1000
CHICAGO, IL 60611 - Phone
- (312) 695-9797
Quick Facts
- NPI
- 1528092871
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile